Effect of age on surgical outcomes of extended gastrectomy with D2 lymph node dissection in gastric carcinoma: Prospective cohort study

Annals of Surgical Oncology

Volumn 17, Issue 6, 2010, Pages 1589-1596

  Jeong, Oh ^a   Park, Young Kyu ^a   Ryu, Seong Yeob ^a   Kim, Young Jin ^a  

^a Chonnam National University Hwasun Hospital and Medical School   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED STUDY; FEMALE; GASTRECTOMY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LENGTH OF STAY; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; PANCREAS RESECTION; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; RISK FACTOR; SEX DIFFERENCE; STOMACH CARCINOMA; SURGICAL APPROACH; TREATMENT OUTCOME;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CARCINOMA; COHORT STUDIES; FEMALE; GASTRECTOMY; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROSPECTIVE STUDIES; RISK FACTORS; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 77954817544     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-0916-4     Document Type: Article

References (25)

1. Marugame T, Dongmei Q. Comparison of time trends in stomach cancer incidence (1973-1997) in East Asia, Europe and USA, from Cancer Incidence in Five Continents Vol. IV-VIII. Jpn J Clin Oncol. 2007;37:242-243
2. Lee HJ, Yang HK, Ahn YO. Gastric cancer in Korea. Gastric Cancer. 2002;5:177-182
3. Inoue M, Tsugane S. Epidemiology of gastric cancer in Japan. Postgrad Med J. 2005;81:419-424
4. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225-249
5. Msika S, Benhamiche AM, Jouve JL, et al. Prognostic factors after curative resection for gastric cancer. A population-based study. Eur J Cancer. 2000;36:390-396 (Pubitemid 30116737)
6. Zhang XF, Huang CM, Lu HS, et al. Surgical treatment and prognosis of gastric cancer in 2,613 patients. World J Gastroenterol. 2004;10:3405-3408
7. Park DJ, Lee HJ, Kim HH, et al. Predictors of operative morbidity and mortality in gastric cancer surgery. Br J Surg. 2005;92:1099-1102
8. Persiani R, Antonacci V, Biondi A, et al. Determinants of surgical morbidity in gastric cancer treatment. J Am Coll Surg. 2008;207:13-19
9. Wu CW, Hsieh MC, Lo SS, et al. Morbidity and mortality after radical gastrectomy for patients with carcinoma of the stomach. J Am Coll Surg. 1995;181:26-32.
10. Eguchi T, Takahashi Y, Ikarashi M, et al. Is extended lymph node dissection necessary for gastric cancer in elderly patients? Eur J Surg. 2000;166:949-953
11. Gretschel S, Estevez-Schwarz L, Hunerbein M, et al. Gastric cancer surgery in elderly patients. World J Surg. 2006;30:1468-1474
12. Katai H, Sasako M, Sano T, et al. The outcome of surgical treatment for gastric carcinoma in the elderly. Jpn J Clin Oncol. 1998;28:112-115 (Pubitemid 128526031)
13. Bonenkamp JJ, Hermans J, Sasako M, et al. Extended lymphnode dissection for gastric cancer. N Engl J Med. 1999;340:908-914
14. Cuschieri A, Weeden S, Fielding J, et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer. 1999;79:1522-1530
15. Nakajima T. Gastric cancer treatment guidelines in Japan. Gastric Cancer. 2002;5:1-5.
16. Degiuli M, Sasako M, Calgaro M, et al. Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial. Eur J Surg Oncol. 2004;30:303-308
17. Sano T, Sasako M, Yamamoto S, et al. Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy. Japan Clinical Oncology Group study 9501. J Clin Oncol. 2004;22:2767-2773
18. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma. 2nd English edition. Gastric Cancer. 1998; 1:10-24.
19. Furukawa H, Hiratsuka M, Ishikawa O, et al. Total gastrectomy with dissection of lymph nodes along the splenic artery: a pancreas- preserving method. Ann Surg Oncol. 2000;7:669-673
20. Wu CW, Hsiung CA, Lo SS, et al. Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol. 2006;7:309-315
21. Parikh D, Johnson M, Chagla L, et al. D2 gastrectomy: lessons from a prospective audit of the learning curve. Br J Surg. 1996; 83:1595-1599
22. Sasako M, Sano T, Yamamoto S, et al. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med. 2008;359:453-462
23. Cheong O, Kim BS, Yook JH, et al. Modified radical lymphadenectomy without splenectomy in patients with proximal gastric cancer: comparison with standard D2 lymphadenectomy for distal gastric cancer. J Surg Oncol. 2008;98:500-504
24. Ichikura T, Chochi K, Sugasawa H, et al. Modified radical lymphadenectomy (D1.5) for T2-3 gastric cancer. Langenbecks Arch Surg. 2005;390:397-402.
25. Kim W, Song KY, Lee HJ, et al. The impact of comorbidity on surgical outcomes in laparoscopy-assisted distal gastrectomy: A retrospective analysis of multicenter results. Ann Surg. 2008;248: 793-799